BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 8227499)

  • 1. P450IIIA (CYP3A) activity in severely depressed patients.
    Watkins PB; Turgeon DK; Guthrie SK; Remen AL; Grunhaus L
    J Clin Psychopharmacol; 1993 Oct; 13(5):366-8. PubMed ID: 8227499
    [No Abstract]   [Full Text] [Related]  

  • 2. Cytochrome P450 3A proteins are expressed in B lymphocytes but not in T lymphocytes.
    Sempoux C; Stärkel P; Stevens M; Van Den Berge V; Horsmans Y
    Pharmacogenetics; 1999 Apr; 9(2):263-5. PubMed ID: 10376774
    [No Abstract]   [Full Text] [Related]  

  • 3. Dose-dependent inhibition of CYP3A activity by clarithromycin during Helicobacter pylori eradication therapy assessed by changes in plasma lansoprazole levels and partial cortisol clearance to 6beta-hydroxycortisol.
    Ushiama H; Echizen H; Nachi S; Ohnishi A
    Clin Pharmacol Ther; 2002 Jul; 72(1):33-43. PubMed ID: 12152002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limited sampling strategy to predict AUC of the CYP3A phenotyping probe midazolam in adults: application to various assay techniques.
    Kim JS; Nafziger AN; Tsunoda SM; Choo EE; Streetman DS; Kashuba AD; Kulawy RW; Beck DJ; Rocci ML; Wilkinson GR; Greenblatt DJ; Bertino JS
    J Clin Pharmacol; 2002 Apr; 42(4):376-82. PubMed ID: 11936561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amlodipine has a minor effect on cyclosporine metabolism.
    McGregor DO; Bailey RR; Robson RA
    Clin Nephrol; 1997 Nov; 48(5):336. PubMed ID: 9403222
    [No Abstract]   [Full Text] [Related]  

  • 6. CYP3A genetics in drug metabolism.
    Eichelbaum M; Burk O
    Nat Med; 2001 Mar; 7(3):285-7. PubMed ID: 11231620
    [No Abstract]   [Full Text] [Related]  

  • 7. Early postoperative erythromycin breath test correlates with hepatic cytochrome P4503A activity in liver transplant recipients.
    Schmidt LE; Olsen AK; Stentoft K; Rasmussen A; Kirkegaard P; Dalhoff K
    Clin Pharmacol Ther; 2001 Nov; 70(5):446-54. PubMed ID: 11719731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Involvement of cytochrome P4503A in the monohydroxylation of ring A of praziquantel in rat liver microsomes].
    Zhang YJ; Quan YZ
    Yao Xue Xue Bao; 1997; 32(1):5-10. PubMed ID: 11243219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular mechanism of the expression and modulation of CYP3A gene].
    Wang JS; Zhou HH
    Sheng Li Ke Xue Jin Zhan; 1998 Apr; 29(2):173-6. PubMed ID: 12501692
    [No Abstract]   [Full Text] [Related]  

  • 10. Risperidone-carbamazepine interactions: is cytochrome P450 3A involved?
    Lane HY; Chang WH
    J Clin Psychiatry; 1998 Aug; 59(8):430-1. PubMed ID: 9721825
    [No Abstract]   [Full Text] [Related]  

  • 11. Induction of cytochrome P4503A by taxol in primary cultures of human hepatocytes.
    Kostrubsky VE; Lewis LD; Strom SC; Wood SG; Schuetz EG; Schuetz JD; Sinclair PR; Wrighton SA; Sinclair JF
    Arch Biochem Biophys; 1998 Jul; 355(2):131-6. PubMed ID: 9675018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thin-layer chromatographic analysis of human CYP3A-catalyzed testosterone 6 beta-hydroxylation.
    Waxman DJ; Chang TK
    Methods Mol Biol; 1998; 107():153-61. PubMed ID: 14577225
    [No Abstract]   [Full Text] [Related]  

  • 13. Genetics. SNP-ing drugs to size.
    Gura T
    Science; 2001 Jul; 293(5530):595. PubMed ID: 11474082
    [No Abstract]   [Full Text] [Related]  

  • 14. A novel female-specific member of the CYP3A gene subfamily in the mouse liver.
    Sakuma T; Takai M; Endo Y; Kuroiwa M; Ohara A; Jarukamjorn K; Honma R; Nemoto N
    Arch Biochem Biophys; 2000 May; 377(1):153-62. PubMed ID: 10775455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of aortic CYP3A bioactivation of nitroglycerin in vivo.
    Yuan R; Sumi M; Benet LZ
    J Pharmacol Exp Ther; 1997 Jun; 281(3):1499-505. PubMed ID: 9190888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of the erythromycin breath test for in vivo assessments of cytochrome P4503A activity and dosage individualization.
    Chiou WL; Jeong HY; Wu TC; Ma C
    Clin Pharmacol Ther; 2001 Oct; 70(4):305-10. PubMed ID: 11673745
    [No Abstract]   [Full Text] [Related]  

  • 17. Identification and characterization of the cytochrome P450 enzymes involved in N-dealkylation of propafenone: molecular base for interaction potential and variable disposition of active metabolites.
    Botsch S; Gautier JC; Beaune P; Eichelbaum M; Kroemer HK
    Mol Pharmacol; 1993 Jan; 43(1):120-6. PubMed ID: 8423765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation of intestinal and hepatic cytochrome P450 3A activity with use of midazolam as an in vivo probe: effect of ketoconazole.
    Tsunoda SM; Velez RL; von Moltke LL; Greenblatt DJ
    Clin Pharmacol Ther; 1999 Nov; 66(5):461-71. PubMed ID: 10579473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythromycin breath test.
    Watkins PB
    Clin Pharmacol Ther; 2000 May; 67(5):577-8. PubMed ID: 10824637
    [No Abstract]   [Full Text] [Related]  

  • 20. Posttranscriptional elevation of cytochrome P450 3A expression.
    Zangar RC; Hernandez M; Novak RF
    Biochem Biophys Res Commun; 1997 Feb; 231(1):203-5. PubMed ID: 9070249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.